+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biosensors Market with COVID-19 Impact by Type, Product (Wearable, Non-wearable), Technology, Application (POC, Home Diagnostics, Research Lab, Environmental Monitoring, Food & Beverages, Biodefense) and Region - Global Forecast to 2026

  • ID: 5314267
  • Report
  • April 2021
  • Region: Global
  • 223 Pages
  • Markets and Markets
The Biosensors Market is Valued at USD 25.5 Billion in 2021 and is Projected to Reach USD 36.7 Billion by 2026

FEATURED COMPANIES

  • Abbott
  • Conductive Technologies
  • Earlysense
  • Lifesignals
  • Nova Biomedical
  • Universal Biosensors
  • MORE

The biosensors market is valued at USD 25.5 billion in 2021 and is projected to reach USD 36.7 billion by 2026; it is expected to grow at a CAGR of 7.5% from 2021 to 2026. Metal-based nanoparticles can be efficiently used to detect nucleic acid sequences by exploiting their optoelectronic properties. Recent advancements in the field of nanotechnology have led to the utilization of nanomaterials, such as metal nanoparticles, oxide nanoparticles, magnetic nanomaterials, carbon materials, quantum dots, and metallophthalocyanines, to improve the electrochemical signals of biocatalytic events that occur at electrode/electrolyte interface. Nanomaterials, such as carbon nanotubes and indium oxide nanowires, are widely used to manufacture nanotechnology-based biosensors or nanobiosensors. Nanobiosensors have revolutionized the future of disease diagnosis. They are gaining importance in areas such as catalysis, optics, biomedical sciences, mechanics, magnetic, and energy science.



The cost pressure is adversely affecting the growth of the global POC market. This is attributed to reimbursement cuts and lack of sufficient budgets. For instance, in 2013, the US government passed the healthcare reform bill, according to which, manufacturers have to pay a heavy 2.3% annual excise tax on medical devices. Similarly, France has explicitly targeted medical devices for cost containment to recover from the recession. The 2013 French budget included price cuts to the tune of USD 157.6 million on the medical sector (including POC), leading to savings of USD 102.8 million from the ambulatory care sector and USD 54.8 million from hospitals. Expenditure on medical devices (including POC) worldwide is also at risk due to a decrease in the list of healthcare products eligible for reimbursements. These factors create pressure on the global medical devices industry. As a result, manufacturers are finding it increasingly challenging to support prices and preclude margin erosion, with rising competition. Thus, price-cutting measures on medical devices, including POC diagnostics, will pose a key challenge to the growth of the market in the coming years.

Sensor Patch Devices: The fastest type of biosensors market

Sensor patches are devices that are attached to a human body for monitoring a range of vital signs and providing specific treatments when required. Sensor patches are categorized under wearable devices, which have embedded intelligence, connectivity, and increased usability. Sensor patches offer unique opportunities for condition/activity monitoring, feedback, and actuation/delivery services, such as drug delivery or stimulation, localization, identification, personal contextual notifications, information display, and virtual assistance. In simpler terms, these devices can monitor, document, and augment lives, and they can be used to assist people in specialized professional and personal activities. These devices also help in sending information directly to caregivers, as well as allowing remote patient monitoring and detecting diseases at early stages.

Wearable Biosensors: The fastest product segment of the biosensors market

Wearable biosensors have attracted considerable attention because of their potential to change the classical medical diagnostics and continuous health monitoring concepts. Wearable biosensor applications aim to change centralized hospital-based care systems to home-based personal medicine and reduce healthcare cost and time for diagnosis. Nowadays, we can see that wearable biosensors are bringing out a wave of innovation to society. Their comfort and better use can provide a new level of exposure to a patient’s real-time health status. This real-time data availability allows better clinical decisions and results in better health results and more efficient use of health systems. For human society, wearable biosensors may help in the early detection of health events and the avoidance of hospitalization. Such events are expected to boost the market growth of wearable biosensors.

Home Diagnostics: Fastest growing application of Biosensors market

Home diagnostics are not limited to checking body weight and measuring body temperature during sickness, it also includes monitoring health and fitness at home without the intervention of physicians. Tests to monitor blood glucose level, fertility, cholesterol, HIV, vitamin D, influenza, and testosterone can be conducted at home by taking a small sample and loading it into a testing cartridge of biosensor units. These biosensor units are intelligent enough to sense the information and transfer it to the consumer’s smartphone through Bluetooth, providing instant test results and suggestions for improving health. Home diagnostics offers various advantages, such as privacy, convenience, and ease-of-use, and low cost.

North America: The leading region in the global biosensors market

North America is projected to account for the largest size of the global biosensors market from 2021 to 2026. The presence of key industrial players and the early adoption of new technological advancements such as nanotechnology are the main factors for the growth of the biosensors market in North America. The market’s growth is mostly driven by the rise in funding for the research and development of medical devices containing biosensors. Research and development of medical devices are largely dependent on funding and grants. For instance, in 2017, Senseonics Holdings (US), a medical technology company, raised USD 41 million to commercialize its Eversense continuous glucose monitoring system and to support research and development for next-generation versions of the sensor. Similarly, in 2016, Endotronix (US), a developer of wireless and implantable pressure sensors, raised USD 32 million in a Series C round of financing. These investments resulted in the development of biosensors for a range of medical equipment and this drove the market in the historic period.

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows: 

  • By Company Type: Tier 1 - 40%, Tier 2 - 25%, and Tier 3 - 35%
  • By Designation: C-level Executives - 35%, Directors - 28%, and Others - 37%
  • By Region: North America - 48%, Europe - 22%, APAC - 20%, RoW - 10%

Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Cytiva (UK), Dexcom, Inc. (US), Lifescan IP Holdings, LLC (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), ACON Laboratories, Inc. (US), CARDEA BIO INC., (US), Conductive Technologies (US), EarlySense (Israel), Innovative Sensor Technology IST AG (Switzerland), LifeSignals (US), NeuroSky (US), Pinnacle Technology Inc. (US), SD Biosensor, INC. (South Korea), VitalConnect (US), and Xsensio (Switzerland) are a few of the key players in the biosensors market.

Research Coverage:

The report segments the biosensors market and forecasts its size, by value, based on Type(Sensor Patch, Embedded Device), Product (Wearable Biosensors, Non-Wearable Biosensors), Technology (Electrochemical, Optical, Piezoelectric, Thermal, Nanomechanical), Application (POC, Home Diagnostics, Research Labs, Environmental Monitoring, Food & Beverages, Biodefense), and Region (North America, Europe, APAC, and RoW).

The report also provides a comprehensive review of market drivers, restraints, opportunities, and challenges in the biosensors market. The report also covers qualitative aspects in addition to the quantitative aspects of these markets. 

Key Benefits of Buying the Report

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the biosensors market and provides them information on key market drivers, restraints, challenges, and opportunities. The report also covers COVID-19 impact on the biosensors market.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Conductive Technologies
  • Earlysense
  • Lifesignals
  • Nova Biomedical
  • Universal Biosensors
  • MORE

1 Introduction
1.1 Study Objectives
1.2 Definition and Scope
1.3 Study Scope
Figure 1 Biosensors Market Segmentation
1.3.1 Geographic Scope
1.3.2 Inclusions and Exclusions
1.4 Years Considered
1.5 Currency
1.6 Stakeholders
1.7 Summary of Changes

2 Research Methodology
2.1 Research Data
Figure 2 Biosensors Market: Process Flow of Market Size Estimation
Figure 3 Biosensors Market: Research Design
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Industry Insights
2.1.2.2 Breakdown of Primaries
2.1.2.3 Key Data from Primary Sources
2.2 Market Size Estimation
Figure 4 Market Size Estimation Methodology: Supply-Side Analysis
Figure 5 Market Size Estimation Methodology: Approach 2 (Supply Side) - Identification of Revenues Generated by Companies from Micro Server Offerings
2.2.1 Bottom-Up Approach
2.2.1.1 Approach for Arriving at Market Size Using Bottom-Up Analysis (Demand Side)
Figure 6 Market: Bottom-Up Approach
Figure 7 Market Size Estimation Methodology: Bottom-Up Approach for Estimating Size of Biosensors Market
2.2.2 Top-Down Approach
2.2.2.1 Approach for Arriving at Market Size Using Top-Down Analysis (Supply Side)
Figure 8 Market: Top-Down Approach
2.3 Market Breakdown and Data Triangulation
Figure 9 Data Triangulation Methodology
2.4 Research Assumptions
Table 1 Study Assumptions
2.5 Limitations
Figure 10 Limitations of Study

3 Executive Summary
Figure 11 Market for Sensor Patch is Expected to Grow at Higher Rate During Forecast Period
Figure 12 Market for Wearable Biosensors is Expected to Grow at Higher Rate During Forecast Period
Figure 13 Market for Electrochemical Technology to Hold Largest Share in 2026
Figure 14 Point of Care Applications Held Largest Share of Market in 2021
Figure 15 Biosensors Market in APAC to Grow at Highest CAGR from 2021 to 2026

4 Premium Insights
4.1 Attractive Opportunities in Biosensors Market
Figure 16 Rising Demand for Wearable Devices Across Various Countries to Implement More Biosensors Across Poc and Home Diagnostic Applications
4.2 Market in North America, by Country and by Product
Figure 17 Us and Non-Wearable Devices are Expected to Hold Largest Share of North American Biosensors Market in 2021
4.3 Market in Apac, by Application
Figure 18 Poc Application to Hold Largest Share of Market in APAC During Forecast Period
4.4 Market, by Country
Figure 19 Market in China to Grow at Highest CAGR from 2021 to 2026

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 20 Increased Demand for Home-Based Poc Devices due to COVID-19 Pandemic to Drive Market for Biosensors
Figure 21 Impact Analysis of Drivers, Restraints, Opportunities, and Challenges of Market
5.2.1 Drivers
5.2.1.1 Emergence of Nanotechnology-Based Biosensors
5.2.1.2 Significant Technological Advancements in Last Few Years
5.2.1.3 Increasing Use of Biosensors to Monitor Glucose Levels in Individuals with Diabetes
5.2.1.4 Surging Demand for Home-Based Point-Of-Care Devices due to COVID-19 Pandemic
5.2.1.5 Rising Government Initiatives Toward Diagnostics
5.2.2 Restraints
5.2.2.1 Slow Rate of Commercialization and Reluctance in Adopting New Treatment Practices
5.2.2.2 High Costs Involved in R&D
5.2.3 Opportunities
5.2.3.1 Emerging Market in Developing Countries
5.2.3.2 High-Growth Opportunities in Food Industry and Environmental Monitoring Applications
5.2.3.3 High-Growth Opportunities in Wearable Device Market
5.2.4 Challenges
5.2.4.1 Government Regulations - Long Certification and Approval Cycles
5.2.4.2 Pricing Pressure in Poc Market
5.3 Value Chain Analysis
Figure 22 Biosensor Manufacturers Contribute Major Value to Overall Cost of Biosensors
5.4 Biosensors Ecosystem
Figure 23 Biosensors Market Ecosystem
Table 2 Supply Chain
5.5 Porter's Five Forces Analysis
Table 3 Market: Porter's Five Forces Analysis
5.5.1 Degree of Competition
5.5.2 Bargaining Power of Suppliers
5.5.3 Bargaining Power of Buyers
5.5.4 Threat from Substitutes
5.5.5 Threat from New Entrants
5.6 Case Studies for Biosensors Market
5.6.1 I-Stat System Helps Patients at Rochdale Urgent Care Center
5.6.2 Integrated Health Solution Provided Cost Savings and Increased Efficiency
5.6.3 Reducing Maternal Morbidity and Mortality Through Non-Invasive Haemoglobin Monitoring
5.6.4 Improving Mobility for Patients and Reducing False Alarms for Staff at Sub-Acute Children's Hospital
5.6.5 Enabling Seamless Data Transmission from Patient's Home
5.7 Technology Analysis
5.8 Average Selling Price (ASP) Trend Analysis
Figure 24 Average Selling Price of Biosensors, by Product (USD)
5.9 Trade Analysis
Table 4 Export Scenario for Hs Code: 901890, by Country, 2015-2019 (USD Thousand)
Table 5 Import Scenario for Hs Code: 901890, by Country, 2015-2019 (USD Thousand)
5.10 Patent Analysis
5.11 Standards and Regulations Related to Biosensors Market
5.12 Trends/Disruptions Impacting Customer Businesses
Figure 25 Revenue Shift for Biosensors Market

6 Biosensors Market, by Type
6.1 Introduction
Figure 26 Market for Sensor Patch is Expected to Grow at Higher Rate During Forecast Period
Table 6 Market, by Type, 2017-2020 (USD Billion)
Table 7 Market, by Type, 2021-2026 (USD Billion)
6.2 Sensor Patch
6.2.1 These Devices Assist People in Specialized Professional and Personal Activities
Figure 27 Market for Sensor Patch in North America Holds Largest Share
Table 8 Market for Sensor Patch, by Region, 2017-2020 (USD Million)
Table 9 Market for Sensor Patch, by Region, 2021-2026 (USD Million)
6.3 Embedded Device
6.3.1 They Detect Broad Spectrum of Biological Analytes and Show Greater Responses and Success Rates in Medical Laboratories and Food Bioanalyses
Table 10 Market for Embedded Device, by Region, 2017-2020 (USD Billion)
Table 11Market for Embedded Device, by Region, 2021-2026 (USD Billion)

7 Biosensors Market, by Product
7.1 Introduction
Figure 28 Market for Wearable Biosensors is Expected to Grow at Higher Rate During Forecast Period
Table 12 Market, by Product, 2017-2020 (USD Billion)
Table 13 Market, by Product, 2021-2026 (USD Billion)
Table 14 Market, by Product, 2020-2026 (Million Units)
7.2 Wearable Biosensors
Figure 29 Wearable Market in APAC is Expected to Grow at Highest CAGR During Forecast Period
Table 15 Wearable Market, by Region, 2017-2020 (USD Billion)
Table 16 Wearable Market, by Region, 2021-2026 (USD Billion)
Table 17 Wearable Market, by Technology, 2017-2020 (USD Billion)
Table 18 Wearable Biosensors Market, by Technology, 2021-2026 (USD Billion)
7.2.1 Wristwear
7.2.1.1 Offer Real-Time Health and Fitness Tracking and Monitoring
7.2.2 Eyewear
7.2.2.1 Smart Glasses and Smart Lenses to Have Significant Presence in Market in Coming Years
7.2.3 Footwear
7.2.3.1 Help in Monitoring Kilometer Run, Calories Burned, Workout Hours, Blood Pressure, and Other Fitness- and Health-Related Data
7.2.4 Neckwear
7.2.4.1 Trendy Devices That Can Help Monitor Fitness
7.2.5 Bodywear
7.2.5.1 Have Potential to Equip Clothes Used for Daily Wear with Smart Capabilities, Making Detection of Body Movements Possible
7.2.6 Others
Table 19 Wearable Market, by Product, 2017-2020 (USD Billion)
Table 20 Wearable Market, by Product, 2021-2026 (USD Billion)
7.3 Non-Wearable Biosensors
7.3.1 Offer Real-Time On-Site Monitoring of Production Processes
Table 21 Non-Wearable Market, by Region, 2017-2020 (USD Billion)
Table 22 Market, by Region, 2021-2026 (USD Billion)
Table 23 Non-Wearable Biosensors, by Technology, 2017-2020 (USD Billion)
Table 24 Non-Wearable Biosensors, by Technology, 2021-2026 (USD Billion)
7.4 Impact of COVID-19

8 Biosensors Market, by Technology
8.1 Introduction
Figure 30 Biosensors Market for Electrochemical Technology to Hold Largest Share in 2026
Table 25 Market, by Technology, 2017-2020 (USD Billion)
Table 26 Market, by Technology, 2021-2026 (USD Billion)
8.2 Electrochemical Biosensors
Table 27 Biosensors Market for Electrochemical Technology, by Product, 2017-2020 (USD Billion)
Table 28 Market for Electrochemical Technology, by Product, 2021-2026 (USD Billion)
8.2.1 Amperometric Sensors
8.2.1.1 Blood Glucose Sensors
8.2.1.1.1 Suitable for Medical Devices for Monitoring Blood Glucose
Table 29 Glucose Sensors and Devices Approved by Fda During 2019-2020
8.2.2 Potentiometric Sensors
8.2.2.1 Immunosensors
8.2.2.1.1 Enable Label-Free Detection and Quantification of Immune Complex
8.2.3 Conductometric Sensors
8.2.3.1 Conductometric Devices Can be Used to Study Enzymatic Reactions and for Practical Applications, Including Drug Detection in Human Urine and Pollutant Detection in Environmental Testing
8.3 Optical Biosensors
Figure 31 Optical Technology for Wearable Devices is Expected to Experience Highest Growth Rate in Market During Forecast Period
Table 30 Market for Optical Technology, by Product, 2017-2020 (USD Billion)
Table 31 Market for Optical Technology, by Product, 2021-2026 (USD Billion)
8.3.1 SPR
8.3.1.1 Measure Interactions in Real-Time with High Sensitivity and Without Needing Labels
8.3.2 Colorimetric Biosensors
8.3.2.1 Used in Various Applications, Such as Detection and Identification of Virulence Activities
8.3.3 Fluorescence Biosensors
8.3.3.1 Provide Better Sensitivities and Specificities, as Well as Ease of Labeling, while Detection
8.4 Piezoelectric Biosensors
Table 32 Market for Piezoelectric Technology, by Product, 2017-2020 (USD Billion)
Table 33 Market for Piezoelectric Technology, by Product, 2021-2026 (USD Billion)
8.4.1 Acoustic Biosensors
8.4.1.1 Monitor Changes in Physical Properties of Acoustic Waves in Response to Measurand
8.4.2 Microcantilever Biosensors
8.4.2.1 Promising Tool for Detecting Biomolecular Interactions with Improved Accuracy
8.5 Thermal Biosensors
8.5.1 Do Not Require Frequent Recalibration and are Insensitive to Optical and Electrochemical Properties of Sample
Table 34 Market for Thermal Technology, by Product, 2017-2020 (USD Billion)
Table 35 Market for Thermal Technology, by Product, 2021-2026 (USD Billion)
8.6 Nanomechanical Biosensors
8.6.1 Have the Ability to Perform Rapid, Sensitive, and Selective Detection of Biological and Biochemical Entities
Table 36 Market for Nanomechanical Technology, by Product, 2017-2020 (USD Billion)
Table 37 Biosensor Market for Nanomechanical Technology, by Product, 2021-2026 (USD Billion)

9 Biosensors Market, by Component
9.1 Introduction
9.2 Bioreceptor Molecules
9.2.1 Presently, Antibodies and Proteins are Also Used as Bioreceptor Molecules in Biosensors
9.3 Biological Element
9.3.1 Biological Elements are Materials Related to Biomolecules
9.4 Transducer
9.4.1 Transducer is Most Important Component of Biosensors, It Covers Biochemical Activities into Electrical Signals

10 Biosensors Market, by Application
10.1 Introduction
Figure 32 Point of Care Applications Held Largest Market Share of Biosensors Market in 2021
Table 38 Market, by Application, 2017-2020 (USD Million)
Table 39 Market, by Application, 2021-2026 (USD Million)
10.2 Poc
Table 40 Market for Poc Application, by Type, 2017-2020 (USD Billion)
Table 41 Market for Poc Application, by Type, 2021-2026 (USD Billion)
Table 42 Biosensor Market for Poc Application, by Region, 2017-2020 (USD Billion)
Table 43 Biosensor Market for Poc Application, by Region, 2021-2026 (USD Billion)
10.2.1 Glucose Monitoring
10.2.1.1 Rising Prevalence of Diabetes Worldwide, Technological Advancements in Self-Monitoring of Blood Glucose, and Growing Awareness About Poc Testing
Table 44 Biosensor Market for Glucose Monitoring for Poc Application, by Region, 2017-2020 (USD Billion)
Table 45 Market for Glucose Monitoring for Poc Application, by Region, 2021-2026 (USD Billion)
10.2.2 Cardiac Marker
10.2.2.1 Sedentary Urban Lifestyles Causing Increase in Cardiovascular Diseases
Table 46 Market for Cardiac Marker for Poc Application, by Region, 2017-2020 (USD Million)
Table 47 Market for Cardiac Marker for Poc Application, by Region, 2021-2026 (USD Million)
10.2.3 Infectious Disease Detection
10.2.3.1 Detection of Toxins, Bacteria, and Viruses in Variety of Physiological and Environmental Matrices
Figure 33 Infectious Disease Detection of Poc Application Holds Largest Market Share Across North America During Forecast Period
Table 48 Market for Infectious Disease Detection for Poc Application, by Region, 2017-2020 (USD Million)
Table 49 Market for Infectious Disease Detection for Poc Application, by Region, 2021-2026 (USD Million)
10.2.4 Coagulation Monitoring
10.2.4.1 Growing Use of Anticoagulant Therapy, Coupled with Adoption of Self-Testing Kits for Use at Home
Table 50 Biosensors Market for Coagulation Monitoring for Poc Application, by Region, 2017-2020 (USD Million)
Table 51 Market for Coagulation Monitoring for Poc Application, by Region, 2021-2026 (USD Million)
10.2.5 Pregnancy Testing
10.2.5.1 Growing Preference of Women for Confidentiality and Accessibility of Test Results
Table 52 Market for Pregnancy Testing for Poc Application, by Region, 2017-2020 (USD Million)
Table 53 Market for Pregnancy Testing for Poc Application, by Region, 2021-2026 (USD Million)
10.2.6 Blood Gas & Electrolyte Detection
10.2.6.1 Growing Global Aging Population is Significantly Driving Growth of Market
Table 54 Market for Blood Gas & Electrolyte Detection for Poc Application, by Region, 2017-2020 (USD Million)
Table 55 Market for Blood Gas & Electrolyte Detection for Poc Application, by Region, 2021-2026 (USD Million)
10.2.7 Detection of Tumor or Cancer Marker
10.2.7.1 Increasing Number of People Suffering from Cancer and Growth in Investments in Cancer Research
Table 56 Market for Tumor or Cancer Marker for Poc Application, by Region, 2017-2020 (USD Million)
Table 57 Market for Tumor or Cancer Marker for Poc Application, by Region, 2021-2026 (USD Million)
10.2.8 Urinalysis Testing
10.2.8.1 Rising Number of Urinary Tract Infections Among Individuals
Table 58 Market for Urinalysis Testing for Poc Application, by Region, 2017-2020 (USD Million)
Table 59 Market for Urinalysis Testing for Poc Application, by Region, 2021-2026 (USD Million)
10.2.9 Cholesterol Testing
10.2.9.1 Increasing Prevalence of Cvds due to Aging and Obese Population
Table 60 Market for Cholesterol Testing for Poc Application, by Region, 2017-2020 (USD Million)
Table 61 Market for Cholesterol Testing for Poc Application, by Region, 2021-2026 (USD Million)
10.3 Home Diagnostics
Table 62 Market for Home Diagnostics Application, by Type, 2017-2020 (USD Million)
Table 63 Market for Home Diagnostics Application, by Type, 2021-2026 (USD Million)
Figure 34 Market for Home Diagnostic Applications in APAC is Expected to Grow at Highest CAGR During Forecast Period
Table 64 Market for Home Diagnostics Application, by Region. 2017-2020 (USD Billion)
Table 65 Market for Home Diagnostics Application, by Region, 2021-2026 (USD Billion)
10.3.1 Glucose Monitoring
10.3.1.1 Growing Preference for Self-Monitoring Blood Glucose Devices
Table 66 Market for Glucose Monitoring for Home Diagnostics Application, by Region, 2017-2020 (USD Billion)
Table 67 Market for Glucose Monitoring for Home Diagnostics Application, by Region, 2021-2026 (USD Billion)
10.3.2 Pregnancy Testing
10.3.2.1 Need for Portable and User-Friendly Pregnancy Testing Devices
Table 68 Market for Pregnancy Testing for Home Diagnostic Application, by Region, 2017-2020 (USD Million)
Table 69 Market for Pregnancy Testing for Home Diagnostic Application, by Region, 2021-2026 (USD Million)
10.3.3 Cholesterol Testing
10.3.3.1 Growth of Diseases due to Increased Cholesterol Levels in Individuals
Table 70 Market for Cholesterol Testing for Home Diagnostics Application, by Region, 2017-2020 (USD Million)
Table 71 Market for Cholesterol Testing for Home Diagnostics Application, by Region, 2021-2026 (USD Million)
10.4 Research Labs
10.4.1 Need for Biosensor-Based Product Development for Early Monitoring of Diseases
Table 72 Market for Research Lab Application, by Region, 2017-2020 (USD Billion)
Table 73 Market for Research Lab Application, by Region, 2021-2026 (USD Billion)
10.5 Environmental Monitoring
10.5.1 Detection of Contaminants in Complex Matrices with Several Advantages to Enhance Market Growth
Table 74 Market for Environmental Monitoring Application, by Region, 2017-2020 (USD Billion)
Table 75 Market for Environmental Monitoring Application, by Region, 2021-2026 (USD Billion)
10.6 Food & Beverages
10.6.1 Biosensors are Used for Pathogen Detection and are Helping to Meet Stringent Food Standards
Table 76 Market for Food & Beverages Application, by Region, 2017-2020 (USD Billion)
Table 77 Market for Food & Beverages Application, by Region, 2021-2026 (USD Billion)
10.7 Biodefense
10.7.1 Use of Biosensors to Detect Microbial Pathogens During Biological Warfare
Table 78 Market for Biodefense Application, by Region, 2017-2020 (USD Million)
Table 79 Market for Biodefense Application, by Region, 2021-2026 (USD Million)

11 Geographic Analysis
11.1 Introduction
Figure 35 North America Holds Largest Share of Biosensors Market
Table 80 Market by Region, 2017-2020 (USD Billion)
Table 81 Market by Region, 2021-2026 (USD Billion)
11.2 North America
Figure 36 Snapshot: Biosensors Market in North America
Table 82 Market in North America, by Application, 2017-2020 (USD Billion)
Table 83 Market in North America, by Application, 2021-2026 (USD Billion)
Table 84 Market in North America, by Poc Application, 2017-2020 (USD Billion)
Table 85 Market in North America, by Poc Application, 2021-2026 (USD Billion)
Table 86 Market in North America, by Home Diagnostics Application, 2017-2020 (USD Million)
Table 87 Market in North America, by Home Diagnostics Application, 2021-2026 (USD Million)
Table 88 Market for North America, by Type, 2017-2020 (USD Billion)
Table 89 Market for North America, by Type, 2021-2026 (USD Billion)
Table 90 Market for North America, by Product, 2017-2020 (USD Billion)
Table 91 Market for North America, by Product, 2021-2026 (USD Billion)
Figure 37 Us Holds Largest Share of Biosensors Market
Table 92 Market in North America, by Country, 2017-2020 (USD Billion)
Table 93 Market in North America, by Country, 2021-2026 (USD Billion)
11.2.1 US
11.2.1.1 Presence of Key Players That Offer Biosensor-Based Poc Applications in US
11.2.2 Canada
11.2.2.1 Increasing Government Support Likely to Escalate Growth of Biosensors Market in Canada
11.2.3 Mexico
11.2.3.1 Use of Biosensors to Detect Cardiovascular Disorders Propels Market Growth in Mexico
11.3 Europe
Figure 38 Snapshot: Biosensor Market in Europe
Table 94 Market in Europe, by Application, 2017-2020 (USD Billion)
Table 95 Market in Europe, by Application, 2021-2026 (USD Billion)
Table 96 Market in Europe, by Poc Application, 2017-2020 (USD Million)
Table 97 Market in Europe, by Poc Application, 2021-2026 (USD Million)
Table 98 Market in Europe, by Home Diagnostics Application, 2017-2020 (USD Million)
Table 99 Market in Europe, by Home Diagnostics Application, 2021-2026 (USD Million)
Table 100Market in Europe, by Type, 2017-2020 (USD Billion)
Table 101 Market in Europe, by Type, 2021-2026 (USD Billion)
Table 102 Market in Europe, by Product, 2017-2020 (USD Billion)
Table 103 Market in Europe, by Product, 2021-2026 (USD Billion)
Table 104 Market in Europe, by Country, 2017-2020 (USD Billion)
Table 105 Market in Europe, by Country, 2021-2026 (USD Billion)
11.3.1 Germany
11.3.1.1 Monitoring of Chronic Diseases to Escalate Biosensors Market Growth
11.3.2 France
11.3.2.1 Technological Advancements in Healthcare Systems Drive Growth of Market in France
11.3.3 UK
11.3.3.1 Rising Cardiac Diseases and Aging Population are Factors Driving Market Growth in UK
11.3.4 Italy
11.3.4.1 Growing Private Sector Results in Increasing Demand for Biosensors for Various Applications
11.3.5 Rest of Europe
11.4 APAC
Figure 39 Snapshot of Biosensors Market in APAC
Table 106 Market in Apac, by Application, 2017-2020 (USD Billion)
Table 107 Market in Apac, by Application, 2021-2026 (USD Billion)
Table 10Market in Apac, by Poc Application, 2017-2020 (USD Million)
Table 109 Market in Apac, by Poc Application, 2021-2026 (USD Million)
Table 110 Market in Apac, by Home Diagnostics Application, 2017-2020 (USD Million)
Table 111 Market in Apac, by Home Diagnostics Application, 2021-2026 (USD Million)
Table 112 Market in Apac, by Type, 2017-2020 (USD Billion)
Table 113 Market in Apac, by Type, 2021-2026 (USD Billion)
Table 114 Market in Apac, by Product, 2017-2020 (USD Billion)
Table 115 Biosensor Market in Apac, by Product, 2021-2026 (USD Billion)
Figure 40 Biosensor Market in China to Grow at Highest CAGR During Forecast Period
Table 116 Biosensors Market in Apac, by Country, 2017-2020 (USD Billion)
Table 117 Biosensor Market in Apac, by Country, 2021-2026 (USD Billion)
11.4.1 China
11.4.1.1 Government Initiatives Toward Creating Better Healthcare Products and Services Likely to Propel Biosensors Market Growth in China
11.4.2 Japan
11.4.2.1 Increase in Standard of Living, Rise in Health Awareness, and Surge in Aging Population are Key Factors Driving Growth of Biosensors Market in Japan
11.4.3 India
11.4.3.1 Growing Population in India Escalates Demand for Biosensors for Healthcare Services
11.4.4 Rest of APAC
11.5 Row
Table 118 Market in Row, by Application, 2017-2020 (USD Million)
Table 119 Market in Row, by Application, 2021-2026 (USD Million)
Table 120 Market in Row, by Poc Application, 2017-2020 (USD Million)
Table 121 Market in Row, by Poc Application, 2021-2026 (USD Million)
Table 122 Market in Row, by Home Diagnostics Application, 2017-2020 (USD Million)
Table 123 Market in Row, by Home Diagnostics Application, 2021-2026 (USD Million)
Table 124 Market in Row, by Type, 2017-2020 (USD Billion)
Table 125 Market in Row, by Type, 2021-2026 (USD Billion)
Table 126 Market in Row, by Product, 2017-2020 (USD Billion)
Table 127 Market in Row, by Product, 2021-2026 (USD Billion)
Table 128 Market in Row, by Country, 2017-2020 (USD Billion)
Table 129 Market in Row, by Country, 2021-2026 (USD Billion)
11.5.1 South America
11.5.1.1 Growing Environment-Related Concerns Have Boosted Adoption of Biosensors for Environmental Monitoring Applications in South America
11.5.2 Middle East and Africa
11.5.2.1 Significant Government Support and Financial Support from Global Firms for Adoption of Poc Testing Kits Will Drive Market for Biosensors Across Middle East and Africa
11.6 Impact of COVID-19

12 Competitive Landscape
12.1 Overview
12.2 Market Evaluation Framework
Table 130 Overview of Strategies Deployed by Key Biosensors Players
12.2.1 Product Portfolio
12.2.2 Regional Focus
12.2.3 Manufacturing Footprint
12.2.4 Organic/Inorganic Growth Strategies
12.3 Revenue Analysis of Leading Players (2016-2020)
Figure 41 Five Year Revenue Analysis of Top 5 Players in Biosensors Market
12.4 Market Share Analysis: Biosensors Market, 2020
Table 131 Degree of Competition
12.5 Company Evaluation Matrix
12.5.1 Star
12.5.2 Emerging Leader
12.5.3 Pervasive
12.5.4 Participant
Figure 42 Company Evaluation Matrix, 2020
12.6 Startup Evaluation Matrix
Table 132 List of Startup Companies in Biosensors Market
12.6.1 Progressive Company
12.6.2 Responsive Company
12.6.3 Dynamic Company
12.6.4 Starting Block
Figure 43 Startup (SME) Evaluation Matrix, 2020
12.7 Company Product Footprint
Table 133 Company Product Footprint
Table 134 Footprint of Different Sensor Types by Different Companies
Table 135 Footprint of Different Companies Across Different Applications
Table 136 Regional Footprint of Different Companies
12.8 Competitive Situations and Trends
12.8.1 Product Launches and Developments
Table 137 Product Launches and Developments, 2020
12.8.2 Deals
Table 138 Deals, 2019-2021

13 Company Profiles
(Business Overview, Products Offered, Recent Developments, COVID-19 Related Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 Key Players
13.1.1 Abbott
Table 139 Abbott: Business Overview
Figure 44 Abbott: Company Snapshot
13.1.2 Roche
Table 140 Roche: Business Overview
Figure 45 Roche: Company Snapshot
13.1.3 Medtronic
Table 141 Medtronic: Business Overview
Figure 46 Medtronic: Company Snapshot
13.1.4 Bio-Rad Laboratories
Table 142 Bio-Rad Laboratories: Business Overview
Figure 47 Bio-Rad Laboratories: Company Snapshot
13.1.5 Dupont
Table 143 Dupont: Business Overview
Figure 48 Dupont: Company Snapshot
13.1.6 Biosensors International Group
Table 144 Biosensors International Group: Business Overview
13.1.7 Cytiva
Table 145 Cytiva: Business Overview
13.1.8 Dexcom
Table 146 Dexcom: Business Overview
Figure 49 Dexcom: Company Snapshot
13.1.9 Lifescan
Table 147 Lifescan: Business Overview
13.1.10 Masimo
Table 148 Masimo: Business Overview
Figure 50 Masimo: Company Snapshot
13.1.11 Nova Biomedical
Table 149 Nova Biomedical: Business Overview
13.1.12 Universal Biosensors
Table 150 Universal Biosensors: Business Overview
Figure 51 Universal Biosensors: Company Snapshot
13.2 Other Key Players
13.2.1 Acon Laboratories
13.2.2 Cardea Bio
13.2.3 Conductive Technologies
13.2.4 Earlysense
13.2.5 Eastprint Incorporated
13.2.6 Ist Ag
13.2.7 Lifesignals
13.2.8 Neurosky
13.2.9 Pinnacle Technology
13.2.10 Sd Biosensor
13.2.11 Vitalconnect
13.2.12 Xsensio
13.2.13 Zimmer and Peacock

*Details on Business Overview, Products Offered, Recent Developments, COVID-19 Related Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) Might Not be Captured in Case of Unlisted Companies.

14 Appendix
14.1 Discussion Guide

Note: Product cover images may vary from those shown
  • Abbott
  • Acon Laboratories
  • Bio-Rad Laboratories
  • Biosensors International Group
  • Cardea Bio
  • Conductive Technologies
  • Cytiva
  • Dexcom
  • Dupont
  • Earlysense
  • Eastprint Incorporated
  • Ist Ag
  • Lifescan
  • Lifesignals
  • Masimo
  • Medtronic
  • Neurosky
  • Nova Biomedical
  • Pinnacle Technology
  • Roche
  • Sd Biosensor
  • Universal Biosensors
  • Vitalconnect
  • Xsensio
  • Zimmer and Peacock
Note: Product cover images may vary from those shown
Adroll
adroll